Global Gout Therapeutics Market Size was valued nearly USD 1.45 billion by 2015 and is estimated to reach up to USD xx.xx billion by 2025. According to latest study conducted by our analysts and industry experts, the global market is expected to grow at a CAGR of 14.8% during the forecast period, i.e. 2017-2025. Gout is the form of inflammable arthritis that develops in the people who have high uric acid secretion in the blood. The acid can form needle-like crystals in a joint and cause sudden, severe episodes of pain, tenderness, redness, warmth and swelling. An attack of gout can occur suddenly, often waking you up in the middle of the night with the sensation that your big toe is on fire. The affected joint is hot, swollen and so tender that even the weight of the sheet on it may seem intolerable. Gout is characterized by intense joint pain, lingering joint pain, inflammation and redness, and limited range of motion.

Global Gout Therapeutics Market Growth Opportunities (Revenue, Growth) By 2017-2025

This global market study report analysis offers in-depth insights, revenue details, and other vital information regarding the global gout therapeutics market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2025. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global gout therapeutics market report has been segmented on the basis of type, application, and region. It includes the estimation of the market size, in terms of value, with respect to 4 main geographies, namely, North America, Europe, APAC, and RoW.   

Market Dynamics

Gout Therapeutics market is estimated to grow at a CAGR of 14.8% from 2017-2025. The market is expected to grow at a faster pace during the forecast period.  Gout is majorly influenced due to accumulation urate crystals in the joint which in turn can cause inflammation and intense pain of gout attack. These urate crystals are caused due to presence of high level of uric acid in the blood. The uric acid in the blood plays an important role in breaking down purines in the body. Purines are majorly found in some food items such as steak, organ meats and seafood, beer, and various other drinks that are sweetened with fruit sugar. In general, the uric acid dissolves in the blood and the body expels it out through urination. The major risk factors that influence gout in an individual are changing eating habits, and obesity.

Furthermore, the rise in population suffering from gout across the globe and increased prevalence is observed due to the changing lifestyle which has resulted in increased alcohol consumption, increasing consumption of purine diet, rising obesity, and various kidney related disorders. In addition, consumption of biologic drugs such as Rilonacept, Krystexxa, and Canakinumab is expected to increase as these are already introduced in the market. These biologics have the capability to produce strong anti-inflammatory action that has driven the demand for this therapy in the market. Also, multiple other drugs are in the clinical trials phase which are eventually expected to be launched and introduced in the market enabling further growth in gout therapeutics industry. Therefore, increasing awareness about the availability of these therapies in the global market, has encouraged investment across various research and development activities by the existing manufacturers and also the governments.

Segment Analysis 

Based on the product type, the Gout Therapeutics market is segmented as rate-lowering agents, corticosteroids, nonsteroidal anti-inflammatory drugs [NSAIDs], and colchicine. Non-steroidal anti-inflammatory drugs (NSAIDs) was observed to be the dominant drug type in this market during 2018. Usage of NSAIDs is popular due to its ease of availability than other drugs. In addition, its cost effectiveness as compared to other drugs in the market is another factor supporting the growth of this drug class during the forecast period. While, urate-lowering agents drug type is projected to grow at a faster rate among all the covered drug types. These agents are characterized majorly by the existence of xanthine oxidase inhibitor and uricosuric agents.

Based on the disease condition, the gout therapeutics market is segmented as acute gout, and chronic gout. Chronic gout segment dominated the market during 2018, and is expected to maintain this position, as this segment uses urate-lowering agents. Similarly, acute gout is majorly treated with the various NSAID’s and other options.

Regional Analysis

North America to hold the largest market share in this industry, owning to the faster adoption of innovative technologies in developed countries such as U.S. and Canada. Additionally, continuous increase in number of patients suffering from gout, and relatively high number of key manufacturers present in this region. Moreover, rising awareness for treating gout with the help of therapies, and continuous research and development activities focusing on innovating new urate-lowering agents

Global Gout Therapeutics Market Size, Share Analysis By Region 2017

The Asia-Pacific regional market is expected to grow at a faster rate owing to the continuous increase in the investments by the key players, increasing number of patients, along with rising preference for the use of gout treatment therapies. Furthermore, high number of smoking population in this region, and increasing alcohol consumption due to changing lifestyle are other factors which influence higher occurrence of gout among patients and is expected to boost the adoption of gout therapeutics

Global Gout Therapeutics Market Study Objective

1. To forecast the market size of gout treatment therapies market, along with describing and defining the market, in terms of volume and revenue.

2. Market analysis and forecast of gout therapies market on the basis of region, substrate and application or end-use industry.

3. To analyze and elaborate significant factors that will have major impact on the growth of gout therapies market, such as drivers, restraints, challenges and opportunities.

4. Regional analysis of gout therapies market, to induce market size of five global major regions, which include, Europe, North America, South America, Middle East & Africa and Asia Pacific.

5. Strategic analysis of micromarkets, in terms of individual prospects, opportunities, growth trends and their involvement in overall market.

6. To provide detailed analysis of competitive and strategic developments in the gout therapies market like new product launch, partnership & agreement, investment & expansion, and company merger & acquisitions.

7. Analysis of market opportunities for stakeholders, in order to provide a competitive landscape for global market players.

8. To profile major market players, and to analyze their market shares and essential competencies comprehensively.

Bottom-up and top-down are two main approaches that were taken into account to anticipate and validate the market size of gout therapies market, and to reach the anticipated market size of several dependent submarkets. The research and study involved massive utilization of secondary data sources, several directories, private and government websites, and authentic databases, to collect or gather market-oriented as well as technical information for the study of gout therapies market commercially.

Key Players

Major players operating in global Gout Therapeutics market include AstraZeneca (UK), Horizon Pharma plc (Ireland), Takeda Pharmaceutical Company Limited (Japan), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Merck & Co. Inc. (U.S.), Teijin Pharma Limited (Japan), Regeneron Pharmaceuticals, Inc. (U.S.), Ironwood Pharmaceuticals, Inc. (U.S.), JW Pharmaceutical (South Korea), Selecta Biosciences, Inc. (U.S.), Grunenthal Group (Germany).

Global Gout Therapeutics Market Study Report Offer You!

The global market study report gives an idea about market size, share, stock, equity, investment and total price analysis. Also, the report provides comprehensively industry insights with all major factors such as market credit, allocation, demand, distribution, market scope, key players, end user & applications, provisions, livestock, commodities and industry economics analysis, future growth & forecast. The global market report includes all depth data like pre-market emphasis, market survey, market investment, industry advice, portfolio, finance, access, trade, market exploration, industry review and market predication & projection to develop effective strategies for optimizing their market position.